• α-CGRP (mouse, rat) peptide

α-CGRP (mouse, rat) peptide

Not For Human Use, Lab Use Only.

Cat.#: 315976

Special Price 578.10 USD

Availability: 4 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    α-CGRP (mouse, rat) peptide
  • Documents
  • Sequence Shortening
    H-SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge:Cys2-Cys7)
  • Sequence
    H-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys7)
  • Length (aa)
    37
  • Peptide Purity (HPLC)
    97.2%
  • Molecular Formula
    C162H262N50O52S2
  • Molecular Weight
    3806.23
  • CAS No.
    83651-90-5
  • Source
    Synthetic
  • Form
    Powder
  • Description

    α-CGRP (calcitonin gene-related peptide) is a 37-amino acid neuropeptide widely distributed in the brain, including the hippocampus of mice and rats. It is encoded by the calcitonin/α-CGRP gene and has been implicated in modulating neuronal activity and plasticity. Studies show that kainic acid (KA) administration upregulates hippocampal α-CGRP mRNA levels, with peak expression observed 6–12 hours post-treatment, returning to baseline by 24 hours. Immunohistochemical analyses reveal α-CGRP presence in mossy cell somata, terminals, and interneurons of the rodent hippocampus.

    Experimental evidence suggests α-CGRP influences excitotoxicity responses. KA-induced neuronal death in the hippocampal CA3 region is more pronounced in wild-type mice compared to α-CGRP knockout models, indicating a regulatory role in neuronal vulnerability. Further, inhibition of α-CGRP release attenuates KA-mediated pyramidal cell damage, supporting its involvement in excitotoxic pathways. These findings highlight α-CGRP as a modulator of hippocampal neuronal responses to excitatory stimuli.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Park SH, Sim YB, Kim CH, Lee JK, Lee JH, Suh HW. Role of α-CGRP in the regulation of neurotoxic responses induced by kainic acid in mice. Peptides. 2013 Jun;44:158-62. doi: 10.1016/j.peptides.2013.04.001. Epub 2013 Apr 12. PMID: 23587546.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator

  • Dilution Calculator

  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"